The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Milbexime Anthelmintic Market Research Report 2025
Synopsis
Similar to other macrolide antiparasitic drugs, milbexime acts as an agonist of GABA (γ-aminobutyric acid) neurotransmitter in nerve cells, and can also interact with gluten in nerve and muscle cells of invertebrates Amino acid-gated Cl-channel binding. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die. Milbexime also affects the reproductive activity of some parasites by reducing oviposition or inducing abnormal egg production.
Global Milbexime Anthelmintic market is projected to reach US$ 938 million in 2029, increasing from US$ 628 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Milbexime Anthelmintic market research.
Key manufacturers engaged in the Milbexime Anthelmintic industry include Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka and Zhejiang Hisun Pharmaceutical Co., Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Milbexime Anthelmintic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Milbexime Anthelmintic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Milbexime Anthelmintic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Segment by Type
Single Ingredient
Compound Ingredients
Segment by Application
Cat
Dog
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Milbexime Anthelmintic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Similar to other macrolide antiparasitic drugs, milbexime acts as an agonist of GABA (γ-aminobutyric acid) neurotransmitter in nerve cells, and can also interact with gluten in nerve and muscle cells of invertebrates Amino acid-gated Cl-channel binding. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die. Milbexime also affects the reproductive activity of some parasites by reducing oviposition or inducing abnormal egg production.
Global Milbexime Anthelmintic market is projected to reach US$ 938 million in 2029, increasing from US$ 628 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Milbexime Anthelmintic market research.
Key manufacturers engaged in the Milbexime Anthelmintic industry include Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka and Zhejiang Hisun Pharmaceutical Co., Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Milbexime Anthelmintic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Milbexime Anthelmintic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Milbexime Anthelmintic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Segment by Type
Single Ingredient
Compound Ingredients
Segment by Application
Cat
Dog
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Milbexime Anthelmintic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Milbexime Anthelmintic Market Overview
1.1 Product Overview and Scope of Milbexime Anthelmintic
1.2 Milbexime Anthelmintic Segment by Type
1.2.1 Global Milbexime Anthelmintic Market Value Comparison by Type (2023-2029)
1.2.2 Single Ingredient
1.2.3 Compound Ingredients
1.3 Milbexime Anthelmintic Segment by Application
1.3.1 Global Milbexime Anthelmintic Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Other
1.4 Global Milbexime Anthelmintic Market Size Estimates and Forecasts
1.4.1 Global Milbexime Anthelmintic Revenue 2018-2029
1.4.2 Global Milbexime Anthelmintic Sales 2018-2029
1.4.3 Global Milbexime Anthelmintic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Milbexime Anthelmintic Market Competition by Manufacturers
2.1 Global Milbexime Anthelmintic Sales Market Share by Manufacturers (2018-2023)
2.2 Global Milbexime Anthelmintic Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Milbexime Anthelmintic Average Price by Manufacturers (2018-2023)
2.4 Global Milbexime Anthelmintic Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Milbexime Anthelmintic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Milbexime Anthelmintic, Product Type & Application
2.7 Milbexime Anthelmintic Market Competitive Situation and Trends
2.7.1 Milbexime Anthelmintic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Milbexime Anthelmintic Players Market Share by Revenue
2.7.3 Global Milbexime Anthelmintic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Milbexime Anthelmintic Retrospective Market Scenario by Region
3.1 Global Milbexime Anthelmintic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Milbexime Anthelmintic Global Milbexime Anthelmintic Sales by Region: 2018-2029
3.2.1 Global Milbexime Anthelmintic Sales by Region: 2018-2023
3.2.2 Global Milbexime Anthelmintic Sales by Region: 2024-2029
3.3 Global Milbexime Anthelmintic Global Milbexime Anthelmintic Revenue by Region: 2018-2029
3.3.1 Global Milbexime Anthelmintic Revenue by Region: 2018-2023
3.3.2 Global Milbexime Anthelmintic Revenue by Region: 2024-2029
3.4 North America Milbexime Anthelmintic Market Facts & Figures by Country
3.4.1 North America Milbexime Anthelmintic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Milbexime Anthelmintic Sales by Country (2018-2029)
3.4.3 North America Milbexime Anthelmintic Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Milbexime Anthelmintic Market Facts & Figures by Country
3.5.1 Europe Milbexime Anthelmintic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Milbexime Anthelmintic Sales by Country (2018-2029)
3.5.3 Europe Milbexime Anthelmintic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Milbexime Anthelmintic Market Facts & Figures by Country
3.6.1 Asia Pacific Milbexime Anthelmintic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Milbexime Anthelmintic Sales by Country (2018-2029)
3.6.3 Asia Pacific Milbexime Anthelmintic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Milbexime Anthelmintic Market Facts & Figures by Country
3.7.1 Latin America Milbexime Anthelmintic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Milbexime Anthelmintic Sales by Country (2018-2029)
3.7.3 Latin America Milbexime Anthelmintic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Milbexime Anthelmintic Market Facts & Figures by Country
3.8.1 Middle East and Africa Milbexime Anthelmintic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Milbexime Anthelmintic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Milbexime Anthelmintic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Milbexime Anthelmintic Sales by Type (2018-2029)
4.1.1 Global Milbexime Anthelmintic Sales by Type (2018-2023)
4.1.2 Global Milbexime Anthelmintic Sales by Type (2024-2029)
4.1.3 Global Milbexime Anthelmintic Sales Market Share by Type (2018-2029)
4.2 Global Milbexime Anthelmintic Revenue by Type (2018-2029)
4.2.1 Global Milbexime Anthelmintic Revenue by Type (2018-2023)
4.2.2 Global Milbexime Anthelmintic Revenue by Type (2024-2029)
4.2.3 Global Milbexime Anthelmintic Revenue Market Share by Type (2018-2029)
4.3 Global Milbexime Anthelmintic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Milbexime Anthelmintic Sales by Application (2018-2029)
5.1.1 Global Milbexime Anthelmintic Sales by Application (2018-2023)
5.1.2 Global Milbexime Anthelmintic Sales by Application (2024-2029)
5.1.3 Global Milbexime Anthelmintic Sales Market Share by Application (2018-2029)
5.2 Global Milbexime Anthelmintic Revenue by Application (2018-2029)
5.2.1 Global Milbexime Anthelmintic Revenue by Application (2018-2023)
5.2.2 Global Milbexime Anthelmintic Revenue by Application (2024-2029)
5.2.3 Global Milbexime Anthelmintic Revenue Market Share by Application (2018-2029)
5.3 Global Milbexime Anthelmintic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Elanco Animal Health
6.1.1 Elanco Animal Health Corporation Information
6.1.2 Elanco Animal Health Description and Business Overview
6.1.3 Elanco Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Elanco Animal Health Milbexime Anthelmintic Product Portfolio
6.1.5 Elanco Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim Animal Health
6.2.1 Boehringer Ingelheim Animal Health Corporation Information
6.2.2 Boehringer Ingelheim Animal Health Description and Business Overview
6.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolio
6.2.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Animal Health Milbexime Anthelmintic Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 VIRBAC SA
6.4.1 VIRBAC SA Corporation Information
6.4.2 VIRBAC SA Description and Business Overview
6.4.3 VIRBAC SA Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 VIRBAC SA Milbexime Anthelmintic Product Portfolio
6.4.5 VIRBAC SA Recent Developments/Updates
6.5 Krka
6.5.1 Krka Corporation Information
6.5.2 Krka Description and Business Overview
6.5.3 Krka Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Krka Milbexime Anthelmintic Product Portfolio
6.5.5 Krka Recent Developments/Updates
6.6 Zhejiang Hisun Pharmaceutical Co., Ltd
6.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Corporation Information
6.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview
6.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolio
6.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Milbexime Anthelmintic Industry Chain Analysis
7.2 Milbexime Anthelmintic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Milbexime Anthelmintic Production Mode & Process
7.4 Milbexime Anthelmintic Sales and Marketing
7.4.1 Milbexime Anthelmintic Sales Channels
7.4.2 Milbexime Anthelmintic Distributors
7.5 Milbexime Anthelmintic Customers
8 Milbexime Anthelmintic Market Dynamics
8.1 Milbexime Anthelmintic Industry Trends
8.2 Milbexime Anthelmintic Market Drivers
8.3 Milbexime Anthelmintic Market Challenges
8.4 Milbexime Anthelmintic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
